ConductScience.org, home

Gene · 799

CALCR: calcitonin receptor

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CALCR: calcitonin receptor. Genes, record 799. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/799

On this page

Gene

Symbol
CALCR
HGNC
Name
calcitonin receptor
HGNC
NCBI Gene ID
799
NCBI Gene
HGNC ID
HGNC:1440
HGNC
Ensembl
ENSG00000004948
NCBI Gene
Aliases
CRT, CT-R, CTR, CTR1
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P30988Calcitonin receptor47432Ensembl, GeneID, HGNC

Source UniProt

Patents62

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1439517P30988Espacenet
JP 2026004568 A2026-01-1439521P30988Espacenet
WO 2025259600 A22025-12-1814P30988Espacenet
EP 4650780 A22025-11-1911147P30988Espacenet
EP 4641201 A22025-10-2911605P30988Espacenet
JP 2025147176 A2025-10-061998P30988Espacenet
JP 2025147176 A2025-10-061999P30988Espacenet
KR 1020250137070 A2025-09-1717P30988Espacenet
WO 2025186446 A12025-09-1236P30988Espacenet
EP 4613860 A12025-09-1036P30988Espacenet

1 to 10 of 62

See all 62 patents

Drugs11

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
CALCITONINCHEMBL4594242Calcitonin receptor agonistAGONISTChEMBL
CALCITONIN HUMANCHEMBL4594248Calcitonin receptor agonistAGONISTChEMBL
CALCITONIN SALMONCHEMBL3989767Calcitonin receptor agonistAGONISTChEMBL
DAVALINTIDECHEMBL2105635Amylin receptor AMY1, CALCR/RAMP1 agonistAGONISTChEMBL
PRAMLINTIDECHEMBL2103758Amylin receptor AMY2; CALCR/RAMP2 agonistAGONISTChEMBL
PRAMLINTIDECHEMBL2103758Amylin receptor AMY1, CALCR/RAMP1 agonistAGONISTChEMBL
PRAMLINTIDECHEMBL2103758Amylin receptor AMY3; CALCR/RAMP3 agonistAGONISTChEMBL
PRAMLINTIDE ACETATECHEMBL3833353Amylin receptor AMY2; CALCR/RAMP2 agonistAGONISTChEMBL
PRAMLINTIDE ACETATECHEMBL3833353Amylin receptor AMY1, CALCR/RAMP1 agonistAGONISTChEMBL
PRAMLINTIDE ACETATECHEMBL3833353Amylin receptor AMY3; CALCR/RAMP3 agonistAGONISTChEMBL

1 to 10 of 11

See all 11 drugs

Trials63

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07203248CALCITONINClinicalTrials.gov
NCT06619015PRAMLINTIDEPHASE2/PHASE3ClinicalTrials.gov
NCT06046417PRAMLINTIDEPHASE2/PHASE3ClinicalTrials.gov
NCT05805683CALCITONINClinicalTrials.gov
NCT05199714PRAMLINTIDEClinicalTrials.gov
NCT04816890PRAMLINTIDEPHASE2ClinicalTrials.gov
NCT04252612PRAMLINTIDEEARLY_PHASE1ClinicalTrials.gov
NCT04243629PRAMLINTIDEClinicalTrials.gov
NCT04163874PRAMLINTIDEClinicalTrials.gov
NCT04074317PRAMLINTIDEPHASE22024-03-27ClinicalTrials.gov

1 to 10 of 63

See all 63 trials

NIH grants1,946

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCALCR papersNewest fiscal year
P30CA016672Cancer Center Support Grant132025
P30CA008748Cancer Center Support Grant122025
P30DK020572Michigan Diabetes Research Center (MDRC)62025
ZIAAI001066International Research in Cambodia: Tropical Medicine and Vector Research62025
K24AI134990Mentoring in Translational Malaria Genomics42025
P30CA056036Translational Research in Cancer42025
P50CA098252SPORE in Cervical Cancer42025
R01AI124678Elucidating the molecular basis of piperaquine resistance in Plasmodium falciparum42025
R01GM129325ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale Modeling42025
R35GM124749Molecular and Cellular Mechanisms of Copper-Dependent Nutrient Signaling and Metabolism42025

1 to 10 of 1,946Source NIH's project files

See all 1,946 nih grants

Papers3,617

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Structure-guided mapping of ototoxicity-related proteins: drug entry, damage amplification, cell death execution, and endogenous otoprotection.Hear Res202642800300PubTator, text miningPubMed
Reductant-Responsive Squalene Dual-Prodrug Nanoparticles Co-Delivering Doxorubicin and Exatecan for Synergistic Breast Tumor Therapy.Pharmaceutics202642797330PubTator, text miningPubMed
Genome-wide mapping of common and rare variant effects on adiposity across childhood.Nat Genet202642791368PubTator, text miningPubMed
Copper homeostasis in macrophages: regulatory mechanisms and immunological implications.Front Chem202642769650PubTator, text miningPubMed
Genetic and Molecular Determinants of Cancer Therapy-Related Cardiovascular Toxicity.Cardiovasc Toxicol202642763821PubTator, text miningPubMed
A dual-action humanized DKK-1 antibody that activates the Wnt/β-catenin signaling pathway and inhibits the RANKL signaling pathway for osteoporosis therapy.Front Immunol202642723851PubTator, text miningPubMed
Ethylene as a Systems-level Integrator of Plant responses to Drought and Heat stress.J Exp Bot202642712210PubTator, text miningPubMed
Metabolic-cell-death gene trio predicts survival and cuproptosis sensitivity in colorectal cancer.J Gastrointest Oncol202642703393PubTator, text miningPubMed
[64Cu]CuCl2 as a Novel Metabolic Marker of Progression and Survival in Muscle-Invasive Bladder Cancer.Mol Imaging Biol202642686932PubTator, text miningPubMed
Single-neuron connectome of nucleus accumbens.Curr Biol202642679807PubTator, text miningPubMed

1 to 10 of 3,617

See all 3,617 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/799

GET https://conductscience.org/api/genes/v1/799/patents?page=2